Kite Pharmaceuticals, Inc.
Aug 6, 2015

Kite Pharma to Host Second Quarter 2015 Financial Results Conference Call and Webcast

SANTA MONICA, Calif., Aug. 6, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (Nasdaq:KITE) today announced that management will host a conference call and live webcast discussion at 4:30 p.m. Eastern Time on Monday, August 10, 2015, to discuss financial results for the second quarter ended June 30, 2015, and provide a business update.

To access the live conference call via phone, please dial (844) 856-8656. International callers may access the live call by dialing (443) 877-4062. The conference ID number for the live call is 98583072.

The live and archived webcast can be accessed through the Calendar of Events section of the Company's website at Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software. A replay of the webcast will be available on the Company's website for two weeks following the event.

About Kite Pharma

Kite Pharma, Inc., is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on engineered autologous T cell therapy (eACT™) designed to restore the immune system's ability to recognize and eradicate tumors. Kite is based in Santa Monica, CA. For more information on Kite Pharma, please visit

CONTACT: Kite Pharma

         Cynthia M. Butitta

         Chief Financial Officer and Chief Operating Officer


         For Media: Justin Jackson

         For Investor Inquiries: Lisa Burns and Carol Werther

         Burns McClellan


Kite Pharma, Inc. logo

Source: Kite Pharma, Inc.

News Provided by Acquire Media